MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Pioneer Of Angiogenesis Reports Panel Of Biomarkers For Early Cancer Diagnosis

Back to cancer blog Blogs list Cancer blog  


Subscribe To Cancer Blog RSS Feed  RSS content feed What is RSS feed?

Pioneer Of Angiogenesis Reports Panel Of Biomarkers For Early Cancer Diagnosis

Pioneer Of Angiogenesis Reports Panel Of Biomarkers For Early Cancer Diagnosis Judah Folkman
Dr. Judah Folkman, the scientist whose discoveries founded the growing field of angiogenesis research, now reports the finding of a panel of biomarkers in platelets that may permit very early diagnosis of cancer. Working with mice bearing human tumors, Dr. Folkman and Dr. Giannoula Klement found that platelets took up angiogenesis regulatory proteins secreted by these tumors. When the microscopic tumors began to grow new blood vessels and grow, these angiogenesis regulatory proteins began to appear in the plasma as well as in the platelets. If this biomarker can be validated in patients, says Dr. Folkman, it may be used in conjunction with other biomarkers to diagnose the recurrence of cancer years before such a minute tumor burden became symptomatic or able to be located by conventional methods such as imaging.

Dr. Folkman described the work April 2 in the keynote lecture of the American Association of Anatomists meeting, part of Experimental Biology 2006 in San Francisco.

The finding of selective uptake of angiogenesis regulatory proteins secreted by tumors also marks a novel function of platelets, the blood cells responsible for blood coagulation and repair of damaged blood vessels.

The "platelet angiogenesis proteome" provides a stable, sensitive, and reliable biomarker for very early diagnosis of cancer, says Dr. Folkman. It could be used to detect recurrence of cancer or to diagnose a new primary tumor, for example in women with the mutated breast cancer gene who have still not developed a clinically detectable cancer.

In the 1970s, Dr. Folkman proposed a then daring hypothesis that tumors could not grow or metastasize without angiogenesis: growing or recruiting blood vessels in order to have their own blood supply. During prior decades, Dr. Folkman's laboratory also discovered the first angiogenesis inhibitors and initiated clinical trials of antiangiogenesis treatment. Last year, the FDA approved the first angiogenesis inhibitor, Avastin, for patients with advanced color or rectal cancer.

Antiangiogenesis compounds do not attack the tumor, as chemotherapies do, but instead turn off the endothelial cells that are essential for new blood vessel growth. Without a blood supply, the tumor eventually stops growing -- with few if any adverse effects on the organisms. The body also is less likely to become resistant to antiangiogenesis drugs, a common problem with traditional chemotherapy.

In addition to the novel platelet biomarker described at the AAA lecture, the Folkman team also has developed other specific and sensitive angiogenesis-based biomarkers in blood and urine capable of detecting microscopic human cancers in mice. In pre-clinical studies, antiangiogenesis treatment of these mice causes the biomarkers to decline to normal levels.



Posted by: Janet    Source




Did you know?
Dr. Judah Folkman, the scientist whose discoveries founded the growing field of angiogenesis research, now reports the finding of a panel of biomarkers in platelets that may permit very early diagnosis of cancer. Working with mice bearing human tumors, Dr. Folkman and Dr. Giannoula Klement found that platelets took up angiogenesis regulatory proteins secreted by these tumors. When the microscopic tumors began to grow new blood vessels and grow, these angiogenesis regulatory proteins began to appear in the plasma as well as in the platelets. If this biomarker can be validated in patients, says Dr. Folkman, it may be used in conjunction with other biomarkers to diagnose the recurrence of cancer years before such a minute tumor burden became symptomatic or able to be located by conventional methods such as imaging.

Medicineworld.org: Pioneer Of Angiogenesis Reports Panel Of Biomarkers For Early Cancer Diagnosis

Main Page| Cancer blog| Cancer blogs list| Lung cancer blog| Colon cancer blog| Prostate cancer blog| Breast cancer blog| Diabetes watch blog| Heart watch blog| Allergy blog| Bladder cancer blog| Cervical cancer blog| Colon cancer news blog| Diabetes news blog| Esophageal cancer blog| Gastric cancer blog| Health news blog| Heart news blog| Infectious disease blog| Kidney watch blog| Lung disease blog| Lung cancer news blog| Mesothelioma blog| Neurology blog| Breast cancer news blog| OBGYN blog| Ophthalmology blog| Ovarian cancer blog| Cancer news blog| Pancreas cancer blog| Pediatrics blog| Prostate cancer news blog| Psychology blog| Research blog| Rheumatology blog| Society news blog| Uterine cancer blog| Weight watch blog|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.